Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 1631 entries
View as:

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT00930982 Org: User:
Start: 06/30/09 End: 09/30/10 Due: 09/30/11

Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT04157088 Org: User:
Start: 12/17/19 End: 07/08/22 Due: 07/08/23

Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073307 Org: User:
Start: 11/30/03 End: 04/30/10 Due: 04/30/11

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01345656 Org: User:
Start: 05/09/11 End: 07/16/12 Due: 07/16/13

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01388153 Org: User:
Start: 06/30/11 End: 08/31/11 Due: 08/31/12

Efficacy and Safety of Primovist in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00526188 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites

Phase: N/A Priority: Normal
NCT ID: NCT01083264 Org: User:
Start: 10/31/09 End: 05/31/10 Due: 05/31/11

A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05351892 Org: User:
Start: 05/04/22 End: 06/20/22 Due: 06/20/23

Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study

Phase: N/A Priority: Normal
NCT ID: NCT04534452 Org: User:
Start: 05/12/12 End: 06/06/12 Due: 06/06/13

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT01010100 Org: User:
Start: 08/31/00 End: 05/31/07 Due: 05/31/08

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

Phase: N/A Priority: Normal
NCT ID: NCT00905684 Org: User:
Start: 06/30/09 End: 12/31/11 Due: 12/31/12

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

Phase: N/A Priority: Normal
NCT ID: NCT01783886 Org: User:
Start: 02/28/13 End: 03/31/15 Due: 03/31/16

Bleeding Pattern Study

Phase: N/A Priority: Normal
NCT ID: NCT00302666 Org: User:
Start: 06/30/03 End: 02/28/05 Due: 02/28/06

Xarelto Regulatory Post-Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01029743 Org: User:
Start: 12/31/09 End: 01/31/16 Due: 01/31/17

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Phase: N/A Priority: Normal
NCT ID: NCT01447043 Org: User:
Start: 01/31/09 End: 11/30/12 Due: 11/30/13

Sorafenib Long Term Extension Program

Phase: N/A Priority: Normal
NCT ID: NCT00625378 Org: User:
Start: 12/21/07 End: 09/24/21 Due: 09/24/22

First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01723475 Org: User:
Start: 11/02/12 End: 09/26/18 Due: 09/26/19

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

Phase: N/A Priority: Normal
NCT ID: NCT03939767 Org: User:
Start: 05/12/19 End: 10/17/23 Due: 10/17/24

A Phase IV Study of Cipro XR in Uncomplicated UTI

Phase: N/A Priority: Normal
NCT ID: NCT00663806 Org: User:
Start: 02/28/03 End: 07/31/03 Due: 07/31/04

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00396786 Org: User:
Start: 11/30/04 End: 07/31/05 Due: 07/31/06

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04848467 Org: User:
Start: 10/01/21 End: 11/15/22 Due: 11/15/23

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

Phase: N/A Priority: Normal
NCT ID: NCT00769171 Org: User:
Start: 10/31/05 End: 01/31/07 Due: 01/31/08

Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)

Phase: N/A Priority: Normal
NCT ID: NCT03092999 Org: User:
Start: 03/28/17 End: 07/17/17 Due: 07/17/18

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04174859 Org: User:
Start: 12/10/19 End: 12/12/22 Due: 12/12/23

An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry Skin

Phase: N/A Priority: Normal
NCT ID: NCT06747897 Org: User:
Start: 11/28/24 End: 12/12/24 Due: 12/12/25